Results: 13
Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 231, doi. 10.1007/s40801-022-00300-y
- By:
- Publication type:
- Article
Context and Considerations for Use of Two Japanese Real-World Databases in Japan: Medical Data Vision and Japanese Medical Data Center.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 175, doi. 10.1007/s40801-022-00296-5
- By:
- Publication type:
- Article
Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 189, doi. 10.1007/s40801-022-00295-6
- By:
- Publication type:
- Article
Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 199, doi. 10.1007/s40801-021-00289-w
- By:
- Publication type:
- Article
Estimating the National Population of Hospitalized Chronic Baclofen Users: A Cross-Sectional Analysis of a Commercial Claims Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 307, doi. 10.1007/s40801-022-00293-8
- By:
- Publication type:
- Article
The Sex-Specific Impact of the FORTA (Fit-fOR-The-Aged) List on Medication Quality and Clinical Endpoints in Older Hospitalized Patients: Secondary Analysis of a Randomized Controlled Trial.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 287, doi. 10.1007/s40801-022-00292-9
- By:
- Publication type:
- Article
Evaluation of the Effect of Topiroxostat on Renal Function in Patients with Hyperuricemia: STOP-C Study, a Retrospective Observational Cohort Study.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 299, doi. 10.1007/s40801-022-00291-w
- By:
- Publication type:
- Article
Treatment Patterns and Pharmacoutilization in Patients Affected by Psoriasis: An Observational Study in an Italian Real-World Setting.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 243, doi. 10.1007/s40801-021-00290-3
- By:
- Publication type:
- Article
Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 275, doi. 10.1007/s40801-022-00294-7
- By:
- Publication type:
- Article
Pharmaceutical Interventions on Hospital Discharge Prescriptions: Prospective Observational Study Highlighting Challenges for Community Pharmacists.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 253, doi. 10.1007/s40801-021-00288-x
- By:
- Publication type:
- Article
Real-World Treatment Patterns and Health-Resource Utilization in Patients with Hepatocellular Carcinoma (HCC) Following Failure of Sorafenib: A Retrospective Chart Review of 127 Patients in South Korea.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 263, doi. 10.1007/s40801-021-00286-z
- By:
- Publication type:
- Article
Thromboembolism and Oral Contraceptives During the COVID-19 Pandemic: A Disproportionality Analysis Within the Spanish Pharmacovigilance Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 211, doi. 10.1007/s40801-021-00282-3
- By:
- Publication type:
- Article
Medical Costs Associated with Insomnia Treatment with Suvorexant Monotherapy in Japan: Results from a Retrospective Cohort Study Using a Large-Scale Claims Database.
- Published in:
- Drugs - Real World Outcomes, 2022, v. 9, n. 2, p. 219, doi. 10.1007/s40801-021-00279-y
- By:
- Publication type:
- Article